Cargando…

The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes

Mostrar otras versiones (1)

Exposure histories to SARS-CoV-2 variants and vaccinations will shape the specificity of antibody responses. To understand the specificity of Delta-elicited antibody immunity, we characterize the polyclonal antibody response elicited by primary or mRNA vaccine-breakthrough Delta infections. Both typ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greaney, Allison J., Eguia, Rachel T., Starr, Tyler N., Khan, Khadija, Franko, Nicholas, Logue, Jennifer K., Lord, Sandra M., Speake, Cate, Chu, Helen Y., Sigal, Alex, Bloom, Jesse D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936118/ https://www.ncbi.nlm.nih.gov/pubmed/35313588 http://dx.doi.org/10.1101/2022.03.12.484088

Ejemplares similares

The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
por: Greaney, Allison J., et al.
Publicado: (2022)

A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
por: Greaney, Allison J., et al.
Publicado: (2021)

A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
por: Greaney, Allison J., et al.
Publicado: (2022)

An antibody-escape calculator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J., et al.
Publicado: (2021)

An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J, et al.
Publicado: (2022)

Receptor binding domain (RBD) antibodies contribute more to SARS-CoV-2 neutralization when target cells express high levels of ACE2
por: Farrell, Ariana Ghez, et al.
Publicado: (2022)

Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2
por: Farrell, Ariana Ghez, et al.
Publicado: (2022)

Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
por: Starr, Tyler N., et al.
Publicado: (2021)

Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
por: Starr, Tyler N., et al.
Publicado: (2021)

Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains
por: Starr, Tyler N., et al.
Publicado: (2022)

Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies
por: Greaney, Allison J., et al.
Publicado: (2021)

The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD
por: Greaney, Allison J., et al.
Publicado: (2021)

The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution
por: Moulana, Alief, et al.
Publicado: (2023)

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
por: Greaney, Allison J., et al.
Publicado: (2021)

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
por: Greaney, Allison J., et al.
Publicado: (2021)

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
por: Starr, Tyler N., et al.
Publicado: (2021)

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
por: Starr, Tyler N., et al.
Publicado: (2020)

Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection
por: Greaney, Allison J., et al.
Publicado: (2021)

Co-dominant neutralizing epitopes make anti-measles immunity resistant to viral evolution
por: Greaney, Allison J., et al.
Publicado: (2021)

Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition
por: Greaney, Allison J., et al.
Publicado: (2020)

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
por: Greaney, Allison J., et al.
Publicado: (2021)

Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail
por: Addetia, Amin, et al.
Publicado: (2022)

Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail
por: Addetia, Amin, et al.
Publicado: (2023)

Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice
por: Loes, Andrea N., et al.
Publicado: (2020)

Attenuated influenza virions expressing the SARS-CoV-2 receptor-binding domain induce neutralizing antibodies in mice
por: Loes, Andrea N., et al.
Publicado: (2020)

Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection
por: Garrett, Meghan E, et al.
Publicado: (2022)

ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
por: Starr, Tyler N., et al.
Publicado: (2022)

Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2021)

Epitope mapping of an anti-diacylglycerol kinase delta monoclonal antibody DdMab-1
por: Sano, Masato, et al.
Publicado: (2020)

Phage-DMS: A Comprehensive Method for Fine Mapping of Antibody Epitopes
por: Garrett, Meghan E., et al.
Publicado: (2020)

Identification of B-cell epitopes in an antigen for inducing specific class of antibodies
por: Gupta, Sudheer, et al.
Publicado: (2013)

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Crawford, Katharine H D, et al.
Publicado: (2020)

Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
por: Moulana, Alief, et al.
Publicado: (2022)

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
por: Dong, Jinhui, et al.
Publicado: (2021)

A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
por: Claireaux, Mathieu, et al.
Publicado: (2022)

SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope
por: He, Ping, et al.
Publicado: (2022)

Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccination
por: Garrett, Meghan E., et al.
Publicado: (2021)

Characterization of a Novel Monoclonal Antibody (27H2) Recognizing Human CD34 Class III Epitope
por: Hong, Kwon Pyo, et al.
Publicado: (2010)

Omicron infection enhances Delta antibody immunity in vaccinated persons
por: Khan, Khadija, et al.
Publicado: (2022)

Designing antibodies against LRRK2-targeted tau epitopes
por: Hamm, Matthew, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_18760l71celsibrh29u4i2u490